Abstract:Hydrocortisone is an effective anti-inflammatory drug and also an important intermediate for synthesis of other steroid drugs. The filamentous fungus Absidia orchidis is renowned for biotransformation of acetylated cortexolone through 11 beta-hydroxylation to produce hydrocortisone. However, due to the presence of 11 alpha-hydroxylase in A. orchidis, the 11 alpha-OH by-product epi-hydrocortisone is always produced in a 1:1 M ratio with hydrocortisone. In order to decrease epi-hydrocortisone production, Saccharomyces cerevisiae was engineered in this work as an alternative way to produce hydrocortisone through biotransformation. Through transcriptomic analysis coupled with genetic verification in S. cerevisiae, the A. orchidis steroid 11 beta-hydroxylation system was characterized, including a cytochrome P450 enzyme CYP5311B2 and its associated redox partners cytochrome P450 reductase and cytochrome b5. CYP5311B2 produces a mix of stereoisomers containing 11 beta-hydroxylation derivatives in a 4:1 M ratio. This fungal steroid 11 beta-hydroxylation system was reconstituted in S. cerevisiae for hydrocortisone production, resulting in a productivity of 22 mg/L.d. Protein engineering of CYP5311B2 generated a R126D/Y398F variant, which had 3 times higher hydrocortisone productivity compared to the wild type. Elimination of C20-hydroxylation by-products and optimization of the expression of A. orchidis 11 beta-hydroxylation system genes further increased hydrocortisone productivity by 238% to 223 mg/L.d. In addition, a novel steroid transporter CICDR4 gene was identified from Cochliobolus lunatus, overexpression of which further increased hydrocortisone productivity to 268 mg/L.d in S. cerevisiae. Through increasing cell mass, 1060 mg/L hydrocortisone was obtained in 48 h and the highest productivity reached 667 mg/L.d. This is the highest hydrocortisone titer reported for yeast biotransformation system so far.

Research advances of hydrocortisone synthesis

A novel synthesis of tetrahydrocortisone 3-glucuronide

Identification of Absidia Orchidis Steroid 11Β-Hydroxylation System and Its Application in Engineering Saccharomyces Cerevisiae for One-Step Biotransformation to Produce Hydrocortisone.

Enhanced Biocatalytic Production of Cortisol by Protein Engineering and Process Engineering

Synthesis of Hydrocortisone Glycosylamine Derivatives

Investigation on the synthesis of 25-hydroxycholesterol.

A Biocatalytic Hydroxylation-Enabled Unified Approach to C19-hydroxylated Steroids.

Divergent Chemo‐ and Biocatalytic Route to 16β‐methylcorticoids: Asymmetric Synthesis of Betamethasone Dipropionate, Clobetasol Propionate, and Beclomethasone Dipropionate

Synthesis, Anti-Inflammatory Activity And Safety Of Hydrocortisone Derivatives Coupled With Furoxans And Nitrates

Practical and scalable synthesis of beclomethasone dipropionate

Glucocorticoids-based Prodrug Design: Current Strategies and Research Progress

Optimisation of Hydrocortisone Production by Curvularia lunata

Preparative Separation of Hydrocortisone and Its Stereoisomer by High‐Speed Countercurrent Chromatography

Determination and Occurrence of Natural and Synthetic Glucocorticoids in Surface Waters

Recent developments in the enzymatic modifications of steroid scaffolds

A novel strategy for development of glucocorticoids through non-genomic mechanism

Biomedical Applications of Supramolecular Materials in the Controllable Delivery of Steroids

Practical Synthesis of 16Α-Bromo-17α-hydroxysteroids Via a Raney Ni-catalyzed Bromide Exchange Reaction

Effectiveness and safety of continuous subcutaneous hydrocortisone infusion in managing adrenocortical insufficiency in adult patients: a systematic review

Design and Synthesis of Furoxan-Based Nitric Oxide-Releasing Glucocorticoid Derivatives with Potent Anti-Inflammatory Activity and Improved Safety

Therapeutic innovations in endocrine diseases - Part 2: Modified-release glucocorticoid compounds: What good do they provide to the adrenal insufficient patient?